First Time Loading...

Cumberland Pharmaceuticals Inc
NASDAQ:CPIX

Watchlist Manager
Cumberland Pharmaceuticals Inc Logo
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Watchlist
Price: 1.76 USD 3.53% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

CPIX Price Targets Summary
Cumberland Pharmaceuticals Inc

Wall Street analysts forecast CPIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPIX is 8.5 USD .

CPIX Lowest Forecast
Wall Street Target
Not Available
CPIX Average Forecast
Wall Street Target
8.5 USD
383% Upside
CPIX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
8.5 USD
383% Upside
Highest
Price Target
Not Available
Cumberland Pharmaceuticals Inc Competitors:
Price Targets
ALM
Almirall SA
36% Upside
LUPIN
Lupin Ltd
13% Downside
RX
Biosyent Inc
8% Upside
PAHC
Phibro Animal Health Corp
14% Downside
ALM
Almirall SA
36% Upside
LUPIN
Lupin Ltd
13% Downside
RX
Biosyent Inc
8% Upside
PAHC
Phibro Animal Health Corp
14% Downside
300039
Shanghai Kaibao Pharmaceutical Co Ltd
16% Upside
KLBF
Kalbe Farma Tbk PT
28% Upside
ALKEM
Alkem Laboratories Ltd
1% Upside
BAI
BenevolentAI SA
292% Upside

Revenue
Forecast

Revenue Estimate
Cumberland Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Cumberland Pharmaceuticals Inc's revenue is 2%. The projected CAGR for the next 3 years is -2%.

2%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cumberland Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cumberland Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
What are analyst estimates?

See Also

Summary
CPIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CPIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CPIX stock valuation using valuation multiples.
Wall Street Estimates
CPIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CPIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPIX's stock price target?
Price Target
8.5 USD

According to Wall Street analysts, the average 1-year price target for CPIX is 8.5 USD .

What is Cumberland Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Cumberland Pharmaceuticals Inc's revenue is 2%. The projected CAGR for the next 3 years is -2%.

ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.